Desktop Site
|
24 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,852.94
+114.49
+0.16 %
Corporate Announcement
Security Code
524804
Company
Aurobindo Pharma Ltd
Exchange Received Time
18/05/2019 16:41:36
Exchange Disseminated Time
18/05/2019 16:41:45
Time Taken
00:00:09
Board Meeting Intimation for Board Meeting To Consider The Audited Financial Results Of The Company For The Fourth Quarter And Year Ended March 31, 2019. |
5/18/2019 4:41:37 PM
AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 ,inter alia, to consider and approve We hereby inform pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a Meeting of the Board of Directors of the Company will be held on Tuesday, May 28, 2019 to consider, inter alia, the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2019.
Further to our letter dated April 3, 2019 informing the closure of Trading Window of the Company from April 4, 2019 until 48 hours from the date of declaration of the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2019, we would like to inform you that the Trading Window will be closed up to May 30, 2019 and shall be re-opened on May 31, 2019.
Attachment
<< Back
Recently Viewed